Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06571955

ACL Reconstruction with a New Generation of LARS Artificial Ligament

Anterior Cruciate Ligament (ACL) Reconstruction with a New Generation of LARS Artificial Ligament

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
MOVMEDIX · Industry
Sex
All
Age
41 Years
Healthy volunteers
Not accepted

Summary

This clinical investigation is intended to demonstrate the safety of the new generation of LARS ligaments and compare this new generation (grafted ligament) of artificial ligament to the LARS current artificial ligament (non-grafted ligament) which is CE marked since 1997, in case of ACL injury. The new generation of LARS artificial ligament is expected to improve physiological response by enhancing fibroblast proliferation, fibroblast organization and collagen type I \& III secretion. This physiological response leads to a better osseo-integration of the ligaments. Therefore, the study is expected to demonstrate the investigational device safety and biomechanical improvements.

Detailed description

Forty subjects over 40 years old with acute ACL injury will be included. A follow-up program is planned over 1 year per subject (days 7, 15, 30, 60, 90, 180, 365) based on physical therapy, biological analysis and biomechanical measurements.

Conditions

Interventions

TypeNameDescription
DEVICEImplantation of LARS artificial grafted ligament to treat ACL injuryImplantation procedure will be realized by a well-trained orthopaedic surgeon and will consist of ACL repair using LARS artificial grafted ligament.
DEVICEImplantation of LARS artificial non-grafted ligament to treat ACL injuryImplantation procedure will be realized by a well-trained orthopaedic surgeon and will consist of ACL repair using LARS artificial non-grafted ligaments.

Timeline

Start date
2021-12-22
Primary completion
2024-03-28
Completion
2024-12-31
First posted
2024-08-26
Last updated
2024-10-21

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06571955. Inclusion in this directory is not an endorsement.

ACL Reconstruction with a New Generation of LARS Artificial Ligament (NCT06571955) · Clinical Trials Directory